MX2009006845A - Composicion herbal y proceso para su preparacion. - Google Patents

Composicion herbal y proceso para su preparacion.

Info

Publication number
MX2009006845A
MX2009006845A MX2009006845A MX2009006845A MX2009006845A MX 2009006845 A MX2009006845 A MX 2009006845A MX 2009006845 A MX2009006845 A MX 2009006845A MX 2009006845 A MX2009006845 A MX 2009006845A MX 2009006845 A MX2009006845 A MX 2009006845A
Authority
MX
Mexico
Prior art keywords
herbal composition
preparation
treatment
glivec
gleevec
Prior art date
Application number
MX2009006845A
Other languages
English (en)
Inventor
Kalpana Sanjay Joshi
Vilas Wagh
Somesh Sharma
Original Assignee
Piramal Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Life Sciences Ltd filed Critical Piramal Life Sciences Ltd
Publication of MX2009006845A publication Critical patent/MX2009006845A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/009—Sachets, pouches characterised by the material or function of the envelope
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una composición herbal que comprende una cantidad terapéuticamente efectiva del extracto de hojas de Piper betle como ingrediente activo ya sea solo, o con un excipiente farmacéuticamente aceptable. Se proporciona un proceso para la preparación de la composición herbal. La composición herbal está adaptada para el tratamiento de leucemia mieloide crónica (CML; leucemia mielógena crónica) que muestra resistencia al tratamiento con imatinib (Gleevec(r) o Glivec(r)).
MX2009006845A 2006-12-21 2007-02-20 Composicion herbal y proceso para su preparacion. MX2009006845A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2091MU2006 2006-12-21
PCT/IB2007/050536 WO2008078203A2 (en) 2006-12-21 2007-02-20 Herbal composition and process for its preparation

Publications (1)

Publication Number Publication Date
MX2009006845A true MX2009006845A (es) 2009-07-07

Family

ID=39563024

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009006845A MX2009006845A (es) 2006-12-21 2007-02-20 Composicion herbal y proceso para su preparacion.

Country Status (14)

Country Link
US (1) US8137708B2 (es)
EP (1) EP2120978B1 (es)
JP (1) JP2010513464A (es)
KR (1) KR20090092331A (es)
CN (1) CN101631556A (es)
AU (1) AU2007337744B2 (es)
BR (1) BRPI0720839A2 (es)
CA (1) CA2673264A1 (es)
MX (1) MX2009006845A (es)
NZ (1) NZ577766A (es)
RU (1) RU2009126159A (es)
TW (1) TW200826956A (es)
WO (1) WO2008078203A2 (es)
ZA (1) ZA200904979B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201201865D0 (en) * 2012-02-03 2012-03-21 Buxton Stephan C A bell for a bicycle
KR101733665B1 (ko) 2015-05-06 2017-05-10 재단법인 지능형 바이오 시스템 설계 및 합성 연구단 진세노사이드 Ｆ1 또는 Ｒｇ3을 유효성분으로 포함하는 글리벡 내성 백혈병 예방 또는 치료용 약학 조성물
MY176273A (en) * 2015-06-25 2020-07-27 Fri Batu Maung Compositions containing piper betle extract for prevention and treatment of bacterial diseases in aquatic animals

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08283171A (ja) * 1995-04-07 1996-10-29 Terumo Corp 抗活性酸素剤
JPH09278666A (ja) 1996-04-09 1997-10-28 Res Inst For Prod Dev 抗菌剤およびその製造法
JP4155430B2 (ja) * 1999-04-07 2008-09-24 三省製薬株式会社 皮膚老化抑制剤およびその用途
JP3667568B2 (ja) 1999-07-22 2005-07-06 裕文 渡邊 円定規
JP2001098267A (ja) * 1999-09-30 2001-04-10 Kobayashi Pharmaceut Co Ltd 抗酸化剤及び活性酸素消去剤
US6852344B2 (en) 2000-12-04 2005-02-08 Council Of Scientific And Industrial Research Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof
AU2001230493A1 (en) 2000-12-04 2002-06-18 Council Of Scientific And Industrial Research Activity of extract of piper betle leaves against leishmania
WO2002045730A1 (en) 2000-12-04 2002-06-13 Council Of Scientific And Industrial Research Antimonocytic activity of extracts of piper betel leaves
JP2002212086A (ja) 2001-01-18 2002-07-31 Hosoda Shoten:Kk キンマ抽出エキス
EP2322627A3 (en) 2001-06-14 2011-10-12 The Regents of the University of California Mutations in the BCR-abl tyrosine kinase associated with resistance to STI-571
JP3706906B2 (ja) * 2001-12-19 2005-10-19 独立行政法人農業・生物系特定産業技術研究機構 カフェオイルホモセリン及びラジカル消去剤
US6967034B2 (en) * 2002-05-31 2005-11-22 Council Of Scientific And Industrial Research Herbal-based composition for treating acute and chronic myeloid leukemia
WO2004004708A1 (en) * 2002-07-08 2004-01-15 Council Of Scientific And Industrial Research A pharmaceutical composition useful for treating chronic myeloid leukemia
EP1545536A4 (en) 2002-09-19 2009-11-11 Univ South Florida METHOD OF TREATING LEUKEMIA USING A COMBINATION OF HYDROMAXIC ACID SUBEROYLANILIDE AND IMATINIBE MESYLATE

Also Published As

Publication number Publication date
WO2008078203A2 (en) 2008-07-03
TW200826956A (en) 2008-07-01
US8137708B2 (en) 2012-03-20
CN101631556A (zh) 2010-01-20
CA2673264A1 (en) 2008-07-03
WO2008078203A3 (en) 2009-04-23
KR20090092331A (ko) 2009-08-31
NZ577766A (en) 2012-02-24
EP2120978A2 (en) 2009-11-25
BRPI0720839A2 (pt) 2014-03-18
EP2120978A4 (en) 2011-10-26
RU2009126159A (ru) 2011-01-27
AU2007337744A1 (en) 2008-07-03
ZA200904979B (en) 2012-12-27
JP2010513464A (ja) 2010-04-30
EP2120978B1 (en) 2013-11-27
US20100028472A1 (en) 2010-02-04
AU2007337744B2 (en) 2013-08-01

Similar Documents

Publication Publication Date Title
WO2008034041A3 (en) Therapeutic combinations
UA92637C2 (en) Pyridine[3,4-b]pyrazinones
WO2006096439A3 (en) Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
BRPI0411825B8 (pt) inibidores de p38 quinase a base de heterociclo de 5 elementos, seus processos de preparação e seus usos, bem como composição farmacêutica
WO2008045817A3 (en) Compositions for reducing nicotine withdrawal symptoms and/or tobacco usage
NZ631429A (en) Porous carbon particles for use in the treatment or prevention of liver disease
WO2006079550A3 (en) Alcohol resistant dosage forms
WO2006107745A3 (en) Composition for treatment of menopause
EP2526934A3 (en) Inhibitors of bruton's tyrosine kinase
EP2012780A4 (en) SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBOXAMIDES AS POTENTE PARP HEMMER
WO2009063222A3 (en) Solid compositions
MX2009004771A (es) Compuestos heteroaril triciclicos utiles como inhibidores de janus cinasa.
WO2007106537A3 (en) Aminoquinolones as gsk-3 inhibitors
WO2008144241A3 (en) Altering pharmacokinetics of pirfenidone therapy
MX2007011174A (es) Metodos y formulaciones de metformina para tratar constipacion cronica.
WO2007108010A3 (en) Taste masked pharmaceutical composition for oral solid dosage form and process for preparing the same using magnesium aluminium silicate
WO2006071775A3 (en) Novel compounds useful for bradykinin b1 receptor antagonism
WO2007108947A3 (en) Nitrofuran compounds for the treatment of cancer and angiogenesis
UA100542C2 (ru) Способ лечения и/или профилактики синдрома слабоумия экстрактом, изготовленным из листьев ginkgo biloba
IL205696A0 (en) Heterocyclic derivatives, compositions comprising the same and uses thereof
ZA201003221B (en) Tea composition and process for the manufacture thereof
WO2008123582A1 (ja) テトラヒドロイソキノリン化合物
PL1853232T3 (pl) Trwałe postaci krystaliczne mesylanu bifeprunoksu, postaci dawkowania oraz sposoby ich stosowania
TW200726763A (en) Novel compound